NorthShore Bio
Enabling new discoveries in science and personalized medicine with the first simple, cost effective, solid-state, long read sequencing platform.
- Stage Prototype Ready
- Industry Biotechnology
- Location Seattle, WA, US
- Currency USD
- Founded November 2010
- Employees 6
- Incorporation Type C-corp
- Website northshorebio.com
Company Summary
NorthShore Bio (NSB) is “The molecular information company,” offering life sciences tools & services. NSB has pioneered an unprecedented silicon chip-based “tunable” nanopore platform that dramatically changes the economics of obtaining molecular information. NSB’s patented approach to ‘direct-to-digital’ electronic sequencing is targeting genetic research & diagnostic markets with a high resolution, low cost direct DNA & RNA sequencing platform.
Team
-
Gordon Holt, PhDFounder & CSO
With 30 yrs experience in bio, pharma & silicon integration at the NIH, Oxford Glycosciences and Intel Corporation, Gordon brings a wealth of knowledge and experience. After earning a PhD from Johns Hopkins Medical School, he successfully ran a lab a the NIH for more than 10 years. Gordon became Director of R&D at Oxford Glycosciences where he successfully took a compound from bench to market. He was recruited by Intel's Biochip program.
-
Founder, President & CEO
Jonathan is a serial entrepreneur, forming new businesses for over 20 years. He is co-founder, President & CEO of NorthShore Bio, and an Advisor to Allegory Venture Partners. Prior to NorthShore Bio, Jonathan joined Intel in 2001, and Intel Capital in 2003 where he led business incubation efforts in computing, optics, automotive and biotechnology. Prior to Intel, Jonathan led the formation of engineering & services companies at Mercedes-Benz.
Advisors
-
Malone & AssociatesAccountantUnconfirmed
Previous Investors
-
FoundersUnconfirmedOregon Angel FundUnconfirmedInstitute for Systems Biology (Dr. Leroy Hood)Unconfirmed
-
Keiretsu Forum NorthWestUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.